Our Work
Reversed Pharmacology
A Vulnerability-first therapeutic paradigm
Instead of trying to overpower resistant disease with higher drug doses, TheraStel’s reversed pharmacology concept begins by making diseased cells easier to target — then uses lower-dose therapy to exploit that engineered weakness.
The Core Idea
Create the weakness first. Then treat it.
Reversed pharmacology shifts treatment design away from asking, “How much drug do we need?” and toward asking, “How can we make the target indispensable?”
Traditional Pharmacology
A drug-centered model that often relies on greater potency, higher exposure, or dose escalation to overcome resistance.
Drug/Dose/ Exposure
Goal: overpower disease biology
Reversed Pharmacology
A vulnerability-centered model that first changes the disease state, creating dependency before therapeutic inhibition.
Drug/Dose/ Exposure
Goal: make disease biology targetable
Therapeutic workflow
A two-part strategy with a precision endpoint.
The process is designed to engineer a conditional vulnerability, then exploit that vulnerability with a focused therapeutic intervention.
01
Reprogram the cell state
Modulate signaling, metabolic, or bioelectric pathways to push diseased cells into a more fragile, targetable state.
02
Induce Dependency
The diseased cell becomes more reliant on a specific pathway or survival mechanism, reducing its ability to adapt or escape.
03
Exploit the weakness
​Once the target becomes essential, lower levels of therapeutic inhibition may produce a stronger, more selective effect.
Induce Vulnerability
Target Dependency
Why it Matters
Designed for resistance, toxicity and precision.
By changing the biological context before treatment, reversed pharmacology may improve the way existing therapies are used and create new paths for difficult-to-treat disease states.
Lower Exposure
Potential to reduce the amount of drug needed to produce therapeutic effect.
Reduced Toxicity
Lower dosing may help limit off-target effects and improve tolerability.
Resistance Strategy
Cells that evade conventional therapy may be made newly vulnerable.
Repurposed Therapeutics
Existing drugs may gain new utility when paired with dependency-inducing interventions.